Your session is about to expire
← Back to Search
Meal Replacement
Group 2 for Protein Malnutrition (PDCAAS Trial)
Phase 4
Waitlist Available
Led By David C Voellinger, MD
Research Sponsored by Southeast Bariatrics, PA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
PDCAAS Trial Summary
The purpose of this research study is to compare the varying qualities of protein supplements utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) method and evaluating the clinical outcome related to protein stores and absorption.
PDCAAS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Protein Absorption
Secondary outcome measures
Patient Compliance with Protein Supplement
Patient tolerability and satisfaction of protein supplement
PDCAAS Trial Design
3Treatment groups
Active Control
Group I: Group 2Active Control1 Intervention
full liquid diet utilizing protein supplements with PDCAAS of 0.5-0.99
Group II: Group 3Active Control1 Intervention
full liquid diet utilizing protein supplement with a PDCAAS less than 0.5
Group III: Group 1Active Control1 Intervention
full liquid diet utilizing meal replacements with PDCAAS of 1.0
Find a Location
Who is running the clinical trial?
Southeast Bariatrics, PALead Sponsor
University of North Carolina, CharlotteOTHER
23 Previous Clinical Trials
13,158 Total Patients Enrolled
David C Voellinger, MDPrincipal InvestigatorSoutheast Bariatrics
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger